Intraductal Papillary Neoplasm of the Bile Duct

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organization(s) Biomarker(s) Cancer type Therapy(ies)
EMA (1) FDA (1) HER2-positive Intraductal Papillary Neoplasm of the Bile Duct Zanidatamab